Drug class

Ammonia Absorption Inhibitors for Hepatic Encephalopathy

Although not a formal standalone class in official FDA or ATC classification systems, "ammonia absorption inhibitors for hepatic encephalopathy" describes a functional category of gastrointestinal agents, primarily nonabsorbable disaccharides such as lactulose and lactitol. Read more about Ammonia Absorption Inhibitors for Hepatic Encephalopathy

23 drugs in this class 21 manufacturers

Advertisement

Drugs in Ammonia Absorption Inhibitors for Hepatic Encephalopathy

Showing 1–9 of 23 drugs

LACTULOSE

LAXATIVES · HYPERAMMONEMIA ·+2
PHARMACEU ASSOC

LACTULOSE

LAXATIVES · HYPERAMMONEMIA ·+2
FOXLAND PHARMAC

LACTULOSE

LAXATIVES · HYPERAMMONEMIA ·+2
Lannett Company

LACTULOSE

LAXATIVES · HYPERAMMONEMIA ·+2
TORRENT PHARMAC

LACTULOSE

LAXATIVES · HYPERAMMONEMIA ·+2
ATLANTIC BIOLOG

LACTULOSE

LAXATIVES · HYPERAMMONEMIA ·+2
CARDINAL HEALTH
Filter & compare in the drug finder → Opens the drug finder with Ammonia Absorption Inhibitors for Hepatic Encephalopathy preselected. Add indication or manufacturer filters there.

About Ammonia Absorption Inhibitors for Hepatic Encephalopathy.

Although not a formal standalone class in official FDA or ATC classification systems, "ammonia absorption inhibitors for hepatic encephalopathy" describes a functional category of gastrointestinal agents, primarily nonabsorbable disaccharides such as lactulose and lactitol.

These agents are metabolized by colonic bacteria into organic acids that acidify the intestinal lumen, trapping diffuse ammonia as nonabsorbable ammonium ions and accelerating fecal transit to prevent systemic absorption.

Their therapeutic role is to reduce circulating neurotoxin levels, serving as a first-line intervention for the prevention and acute management of hepatic encephalopathy secondary to liver cirrhosis or severe hepatic insufficiency.